These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9306390)

  • 41. Slow start to phase 0 as researchers debate value.
    Twombly R
    J Natl Cancer Inst; 2006 Jun; 98(12):804-6. PubMed ID: 16788150
    [No Abstract]   [Full Text] [Related]  

  • 42. NIAID declines to proceed with HIV vaccine trial.
    AIDS Policy Law; 2008 Aug; 23(9):1, 4. PubMed ID: 18780467
    [No Abstract]   [Full Text] [Related]  

  • 43. Adenoviral vectors: systemic delivery and tumor targeting.
    Green NK; Seymour LW
    Cancer Gene Ther; 2002 Dec; 9(12):1036-42. PubMed ID: 12522442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
    Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
    Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Scientific and ethical considerations in trial design for investigational agents for the treatment of human immunodeficiency virus infection.
    Feinberg J; Japour AJ
    Clin Infect Dis; 2003 Jan; 36(2):201-6. PubMed ID: 12522753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increasing access to investigational drugs.
    Christian M
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):90-1. PubMed ID: 16163167
    [No Abstract]   [Full Text] [Related]  

  • 47. Gene therapists promise renewed vigor in monitoring as field progresses.
    SoRelle R
    Circulation; 2001 Jan; 103(1):E9001-2. PubMed ID: 11136706
    [No Abstract]   [Full Text] [Related]  

  • 48. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
    Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
    Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exemption from RAC review of certain types of human gene transfer vaccine protocols: interpretation of the term "persistence of the vector encoded immunogen".
    Hum Gene Ther; 2001 Aug; 12(12):1596-7. PubMed ID: 11529250
    [No Abstract]   [Full Text] [Related]  

  • 50. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NIH under fire over gene-therapy trials..
    Wadman M
    Nature; 2000 Jan; 403(6767):237. PubMed ID: 10659820
    [No Abstract]   [Full Text] [Related]  

  • 52. Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facility.
    Grilley BJ; Gee AP
    Cytotherapy; 2003; 5(3):197-207. PubMed ID: 12850787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene therapy. Clinical trials next step.
    Gershon D
    Nature; 1990 Mar; 344(6261):2. PubMed ID: 2406611
    [No Abstract]   [Full Text] [Related]  

  • 54. Gene therapy on the move.
    Culliton BJ
    Nature; 1991 Dec; 354(6353):429. PubMed ID: 1749426
    [No Abstract]   [Full Text] [Related]  

  • 55. Human gene therapy: anticancer trial's surprise approval.
    Gershon D
    Nature; 1990 Aug; 346(6284):497. PubMed ID: 2377212
    [No Abstract]   [Full Text] [Related]  

  • 56. Pediatric drug research--the road less traveled.
    Holdsworth MT
    Ann Pharmacother; 2003 Apr; 37(4):586-91. PubMed ID: 12659620
    [No Abstract]   [Full Text] [Related]  

  • 57. Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA.
    Sausville EA; Feigal E
    Ann Oncol; 1999 Nov; 10(11):1287-91. PubMed ID: 10631454
    [No Abstract]   [Full Text] [Related]  

  • 58. Certified host vector systems.
    Recomb DNA Tech Bull; 1981 Jul; 4(2):75-7. PubMed ID: 6265977
    [No Abstract]   [Full Text] [Related]  

  • 59. Certified host vector systems.
    Recomb DNA Tech Bull; 1982 Jun; 5(2):105-8. PubMed ID: 6312501
    [No Abstract]   [Full Text] [Related]  

  • 60. Certified host vector systems.
    Recomb DNA Tech Bull; 1982 Dec; 5(4):206-9. PubMed ID: 6312506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.